000 | 01939 a2200637 4500 | ||
---|---|---|---|
005 | 20250517132430.0 | ||
264 | 0 | _c20180226 | |
008 | 201802s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.14174 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJiang, Dongxian | |
245 | 0 | 0 |
_aIndependent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma. _h[electronic resource] |
260 |
_bOncotarget _cJan 2017 |
||
300 |
_a8315-8329 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aB7-H1 Antigen _xanalysis |
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _ximmunology |
650 | 0 | 4 | _aChi-Square Distribution |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 |
_aEsophageal Neoplasms _ximmunology |
650 | 0 | 4 | _aEsophageal Squamous Cell Carcinoma |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTissue Array Analysis |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aSong, Qi | |
700 | 1 | _aWang, Haixing | |
700 | 1 | _aHuang, Jie | |
700 | 1 | _aWang, Hao | |
700 | 1 | _aHou, Jun | |
700 | 1 | _aLi, Xiaojing | |
700 | 1 | _aXu, Yifan | |
700 | 1 | _aSujie, Akesu | |
700 | 1 | _aZeng, Haiying | |
700 | 1 | _aTan, Lijie | |
700 | 1 | _aHou, Yingyong | |
773 | 0 |
_tOncotarget _gvol. 8 _gno. 5 _gp. 8315-8329 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.14174 _zAvailable from publisher's website |
999 |
_c26743760 _d26743760 |